Xgen Venture

Xgen Venture company information, Employees & Contact Information

Explore related pages

Related company profiles:

XGEN Venture is a venture capital fund manager established in 2021 by the former Genextra team, that specializes in life science investing. We work with a group of exceptional scientists and entrepreneurs to translate high level science into solutions for patients.

Company Details

Employees
21
Founded
-
Address
Milan, It
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
Keywords
Paris.
HQ
Milan
Looking for a particular Xgen Venture employee's phone or email?

Xgen Venture Questions

News

XGEN Venture Announces Final Closing of €180M ($190M) Life Sciences Fund - Business Wire

XGEN Venture Announces Final Closing of €180M ($190M) Life Sciences Fund Business Wire

XGEN Venture: €180 Million Life Sciences Fund Closes - Pulse 2.0

XGEN Venture: €180 Million Life Sciences Fund Closes Pulse 2.0

XGEN Venture closes $190M fund with plans to invest in early-stage biotech, medtech firms - Fierce Biotech

XGEN Venture closes $190M fund with plans to invest in early-stage biotech, medtech firms Fierce Biotech

Italy’s angels & incubators and venture capital weekly roundup. News from Nanophoria, XGEN Venture, Sofinnova Partners, CDP Venture Capital, Ventive, Vanguard Legacy Capital, Redstone, KON Group, Lorenzo Guidotti, FundX – Fabio Nalucci, and more - BeBeez International

Italy’s angels & incubators and venture capital weekly roundup. News from Nanophoria, XGEN Venture, Sofinnova Partners, CDP Venture Capital, Ventive, Vanguard Legacy Capital, Redstone, KON Group, Lorenzo Guidotti, FundX – Fabio Nalucci, and more BeBeez International

Genespire raises €46.6 million (~$52 million) in a Series B - GlobeNewswire

Genespire raises €46.6 million (~$52 million) in a Series B GlobeNewswire

NanoPhoria Bioscience secures €83.5 Million Series A to Advance Breakthrough Heart Failure Therapy and Expand Portfolio for Novel Nano-in-Micro Delivery Platform - Business Wire

NanoPhoria Bioscience secures €83.5 Million Series A to Advance Breakthrough Heart Failure Therapy and Expand Portfolio for Novel Nano-in-Micro Delivery Platform Business Wire

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant